Smith & Nephew plc Share Price Berne S.E.

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Delayed Berne S.E. 14:05:19 17/04/2023 BST 5-day change 1st Jan Change
- CHF -.--% Intraday chart for Smith & Nephew plc -.--% -100.00%

Financials

Sales 2024 * 5.82B 5.25B 459B Sales 2025 * 6.12B 5.53B 483B Capitalization 11.27B 10.17B 889B
Net income 2024 * 541M 488M 42.69B Net income 2025 * 694M 627M 54.76B EV / Sales 2024 * 2.38 x
Net Debt 2024 * 2.56B 2.31B 202B Net Debt 2025 * 2.23B 2.01B 176B EV / Sales 2025 * 2.21 x
P/E ratio 2024 *
21.9 x
P/E ratio 2025 *
16.8 x
Employees 18,452
Yield 2024 *
2.96%
Yield 2025 *
3.32%
Free-Float 99.15%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0.00000000
15.65
5 years
0.00
Extreme 0.00000000
15.65
10 years
0.00
Extreme 0.00000000
15.65
More quotes
Managers TitleAgeSince
Chief Executive Officer - 31/03/22
Director of Finance/CFO 56 11-30
Compliance Officer - 31/03/99
Members of the board TitleAgeSince
Director/Board Member 65 30/09/17
Director/Board Member 62 13/09/23
Chairman 63 25/04/23
More insiders
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.92 USD
Average target price
16.35 USD
Spread / Average Target
+26.49%
Consensus